European Commission logo
Deutsch Deutsch
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-27

Advancement of hearing assessement methods and devices - immediate intervention

Ziel

Within the past 3-4 years, scientists and clinicians have demonstrated the feasibility, reliability, and effectiveness of early detection of infants with hearing loss through universal newborn hearing screening (UNHS) based onotoacoustic emissions (Oases). OAE technology has been entirely developed in the Equals as a result of previous EC projects (Biomedicine & Health). UNHS is becoming standard of care in the most advanced maternity clinics. Oases are produced byte outer hair cells. They contain contractile proteins, play a crucial role in peripheral coding under the control of higher neural centres and are essential to normal cochlear function. Absence or alterations of Oases is the method to assess even mild peripheral hearing losses. These technologies were entirely developed in Europe and are being applied by European manufacturers who still maintain the technical leadership in the field (with a share of almost 90% of the whole market).

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

THN - Thematic network contracts

Koordinator

NATIONAL RESEARCH COUNCIL OF ITALY
EU-Beitrag
Keine Daten
Adresse
Piazza Leonardo Da Vinci 32
20133 MILANO
Italien

Auf der Karte ansehen
Gesamtkosten
Keine Daten

Beteiligte (50)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 12 April 2005

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/QLG5-CT-2000-01613/de

European Union, 2024